{"id":2105,"date":"2008-03-13T09:00:50","date_gmt":"2008-03-13T16:00:50","guid":{"rendered":"http:\/\/www.carlsbadistan.com\/?p=2105"},"modified":"2008-03-13T09:01:02","modified_gmt":"2008-03-13T16:01:02","slug":"isis-loses-less-in-fourth-quarter","status":"publish","type":"post","link":"https:\/\/www.carlsbadistan.com\/?p=2105","title":{"rendered":"Isis Loses Less In Fourth Quarter"},"content":{"rendered":"<p><a href=\"http:\/\/www.carlsbadistan.com\/wp-content\/uploads\/2008\/03\/home-rightpic.jpg\" onclick=\"window.open('http:\/\/www.carlsbadistan.com\/wp-content\/uploads\/2008\/03\/home-rightpic.jpg','popup','width=435,height=295,scrollbars=no,resizable=yes,toolbar=no,directories=no,location=no,menubar=no,status=yes,left=0,top=0');return false\"><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/www.carlsbadistan.com\/wp-content\/uploads\/2008\/03\/home-rightpic-tm.jpg\" height=\"135\" width=\"200\" border=\"1\" align=\"right\" hspace=\"4\" vspace=\"4\" alt=\"Home Rightpic\" \/><\/a>Carlsbad&#8217;s leading pharmaceutical company <strong><a href=\"http:\/\/www.isispharm.com\/\" target=\"_blank\">Isis<\/a><\/strong> announced today that they only lost $7 million dollars this quarter compared to a lost of $14.1 million in 2007.<\/p>\n<blockquote><p>Isis&#8217; full-year loss after preferred dividends widened to $136.3 million, or $1.63 per share compared with a loss of $45.9 million, or 62 cents per share, in the previous year. The company said $1.50 of the 2007 per-share loss was attributable to the $120 million purchase of Symphony GenIsis.<\/p><\/blockquote>\n<p>There are millions in this business somewhere. <\/p>\n<p><strong>[Link: <\/strong><strong><a href=\"http:\/\/www.forbes.com\/markets\/feeds\/afx\/2008\/03\/13\/afx4767674.html\" target=\"_blank\">Forbes.com<\/a><\/strong><strong>]<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Carlsbad&#8217;s leading pharmaceutical company Isis announced today that they only lost $7 million dollars this quarter compared to a lost of $14.1 million in 2007. Isis&#8217; full-year loss after preferred dividends widened to $136.3 million, or $1.63 per share compared with a loss of $45.9 million, or 62 cents per share, in the previous year. [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[8,34],"tags":[],"_links":{"self":[{"href":"https:\/\/www.carlsbadistan.com\/index.php?rest_route=\/wp\/v2\/posts\/2105"}],"collection":[{"href":"https:\/\/www.carlsbadistan.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.carlsbadistan.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.carlsbadistan.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.carlsbadistan.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2105"}],"version-history":[{"count":0,"href":"https:\/\/www.carlsbadistan.com\/index.php?rest_route=\/wp\/v2\/posts\/2105\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.carlsbadistan.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2105"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.carlsbadistan.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2105"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.carlsbadistan.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2105"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}